Dr Akheel Syed
Richard Bliss
Dr James Roberts
Dr Ujjal Mallick
Dr Sarah Johnson
et al. | Metachronous testicular teratoma, testicular seminoma and papillary thyroid carcinoma occurring in a single individual: a report of two unrelated cases | 2010 |
|
Professor Ghada Khattab
Dr James Roberts
| Working with Children | 2010 |
|
Dr James Roberts
| Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: A model update and multicentre validation with more than 1000 patients | 2007 |
|
Dr James Roberts
| Long- term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer | 2006 |
|
Dr James Roberts
| Chemotherapy for metastatic bladder cancer | 2005 |
|
Dr James Roberts
| Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer | 2005 |
|
Dr James Roberts
| Modelling the expected increase in demand for particle radiotherapy: implications for the UK | 2005 |
|
Dr James Roberts
| Multidisciplinary teams improve the care of patients with cancer: the case against | 2005 |
|
Dr James Roberts
| Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: A report on medical research council trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) | 2005 |
|
Dr James Roberts
| Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours | 2004 |
|
Mark Pearson
Dr Julian Thomas
Professor Martin Eccles
Dr James Roberts
| NICE clinical guidelines | 2004 |
|
Dr James Roberts
Albert Craig
| Radiotherapy in the UK: There are problems - What are the solutions? | 2004 |
|
Dr James Roberts
| The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part I: locally advanced disease | 2004 |
|
Dr James Roberts
| The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part II: metastatic disease | 2004 |
|
Dr James Roberts
| External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients | 2003 |
|
